Stammdaten
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Unternehmen & Branche
| Name | SOPHiA GENETICS SA |
|---|---|
| Ticker | SOPH |
| CIK | 0001840706 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Information Services |
| SIC | 7374 · Services-Computer Processing & Data Preparation |
Wertpapier & Kennzahlen
| CUSIP | h82027105 |
|---|---|
| ISIN | USH820271056 |
| Typ | Common Stock |
| Marktkapitalisierung | 373,4 Mio. USD |
| Beta | 1,05 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| AKRE CAPITAL MANAGEMENT LLC | 3,719,140 | 0 | 3,719,140 | 17,368,384 | Neu | +100,0% | |
| BANQUE PICTET & CIE SA | 2,208,280 | 0 | 2,208,280 | 10,312,668 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 1,399,442 | 0 | 1,399,442 | 6,535,394 | Neu | +100,0% | |
| ROYCE & ASSOCIATES LP | 430,257 | 0 | 430,257 | 2,009,300 | Neu | +100,0% | |
| Bank Pictet & Cie (Europe) AG | 255,200 | 0 | 255,200 | 1,191,784 | Neu | +100,0% | |
| 1492 Capital Management LLC | 208,345 | 0 | 208,345 | 972,971 | Neu | +100,0% | |
| Ensign Peak Advisors, Inc | 182,414 | 0 | 182,414 | 851,873 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 125,458 | 0 | 125,458 | 585,889 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 92,596 | 0 | 92,596 | 432,423 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 83,000 | 0 | 83,000 | 387,610 | Neu | +100,0% | |
| UBS Group AG | 61,901 | 0 | 61,901 | 289,078 | Neu | +100,0% | |
| MORGAN STANLEY | 48,047 | 0 | 48,047 | 224,380 | Neu | +100,0% | |
| Silverberg Bernstein Capital Management LLC | 47,815 | 0 | 47,815 | 223,296 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 40,400 | 0 | 40,400 | 188,668 | Neu | +100,0% | |
| Pathstone Holdings, LLC | 32,203 | 0 | 32,203 | 150,388 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 30,511 | 0 | 30,511 | 142,486 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 28,660 | 0 | 28,660 | 133,842 | Neu | +100,0% | |
| XTX Topco Ltd | 11,760 | 0 | 11,760 | 54,919 | Neu | +100,0% | |
| Quadrature Capital Ltd | 11,649 | 0 | 11,649 | 54,401 | Neu | +100,0% | |
| PERKINS CAPITAL MANAGEMENT INC | 10,500 | 0 | 10,500 | 49,035 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 5,552 | 0 | 5,552 | 25,928 | Neu | +100,0% | |
| BlackRock, Inc. | 5,086 | 0 | 5,086 | 23,752 | Neu | +100,0% | |
| ASSETMARK, INC | 4,687 | 0 | 4,687 | 21,888 | Neu | +100,0% | |
| OSAIC HOLDINGS, INC. | 1,000 | 0 | 1,000 | 4,670 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 600 | 0 | 600 | 3,000 | Neu | +100,0% | |
| United Financial Planning Group LLC | 170 | 0 | 170 | 794 | Neu | +100,0% | |
| SBI Securities Co., Ltd. | 41 | 0 | 41 | 191 | Neu | +100,0% | |
| SIMPLEX TRADING, LLC | 31 | 0 | 31 | 144 | Neu | +100,0% | |
| GSA CAPITAL PARTNERS LLP | 24,967 | 0 | 24,967 | 117 | Neu | +100,0% | |
| FNY Investment Advisers, LLC | 16,010 | 0 | 16,010 | 74 | Neu | +100,0% | |
| ACADIAN ASSET MANAGEMENT LLC | 5,911 | 0 | 5,911 | 27 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | Menu Philippe | Officer, Chief Medical Officer | Open Market Sale | -5,000 | 4.82 | -24,089.00 | -142,8% | |
| 2026-04-20 | Puylaert Kevin | Officer, Chief Sales Officer | Open Market Sale | -33 | 5.08 | -167.69 | -1,0% | |
| 2026-04-20 | Muken Ross | Officer, President | Open Market Sale | -760 | 5.20 | -3,954.96 | -23,4% | |
| 2026-04-20 | Menu Philippe | Officer, Chief Medical Officer | Open Market Sale | -608 | 5.20 | -3,161.72 | -18,7% | |
| 2026-04-20 | Camblong Jurgi | Director, Officer, Chief Executive Officer | Open Market Sale | -4,486 | 5.21 | -23,349.63 | -138,4% | |
| 2026-04-20 | Van Well Daan | Officer, Chief Legal Officer | Open Market Sale | -684 | 5.20 | -3,554.27 | -21,1% | |
| 2026-04-20 | Xu Zhenyu | Officer, Chief Scientific Officer | Open Market Sale | -608 | 5.21 | -3,164.82 | -18,8% | |
| 2026-04-20 | Valente Manuela | Officer, Chief People Officer | Open Market Sale | -380 | 5.20 | -1,977.18 | -11,7% | |
| 2026-04-15 | Camblong Jurgi | Director, Officer, Chief Executive Officer | Open Market Sale | -17,473 | 5.00 | -87,401.69 | -518,1% | |
| 2026-04-14 | Muken Ross | Officer, President | Open Market Sale | -2,800 | 4.96 | -13,887.16 | -82,3% | |
| 2026-04-14 | Camblong Jurgi | Director, Officer, Chief Executive Officer | Open Market Sale | -43,129 | 4.96 | -213,833.58 | -1267,6% | |
| 2026-04-14 | Xu Zhenyu | Officer, Chief Scientific Officer | Open Market Sale | -600 | 4.97 | -2,979.78 | -17,7% | |
| 2026-04-14 | Menu Philippe | Officer, Chief Medical Officer | Open Market Sale | -1,600 | 4.96 | -7,932.96 | -47,0% | |
| 2026-04-13 | Xu Zhenyu | Officer, Chief Scientific Officer | Open Market Sale | -3,400 | 4.76 | -16,196.58 | -96,0% | |
| 2026-04-13 | Menu Philippe | Officer, Chief Medical Officer | Open Market Sale | -3,400 | 4.76 | -16,198.28 | -96,0% | |
| 2026-04-13 | Menu Philippe | Officer, Chief Medical Officer | Open Market Sale | -1,000 | 4.76 | -4,764.20 | -28,2% | |
| 2026-04-13 | Muken Ross | Officer, President | Open Market Sale | -4,442 | 4.77 | -21,166.13 | -125,5% | |
| 2026-04-13 | Camblong Jurgi | Director, Officer, Chief Executive Officer | Open Market Sale | -4,399 | 4.76 | -20,957.28 | -124,2% | |
| 2026-04-13 | Xu Zhenyu | Officer, Chief Scientific Officer | Open Market Sale | -1,014 | 4.76 | -4,830.39 | -28,6% | |
| 2026-04-10 | Muken Ross | Officer, President | Open Market Sale | -3,687 | 4.69 | -17,278.76 | -102,4% | |
| 2026-04-10 | Van Well Daan | Officer, Chief Legal Officer | Open Market Sale | -2,400 | 4.67 | -11,201.28 | -66,4% | |
| 2026-04-10 | Xu Zhenyu | Officer, Chief Scientific Officer | Open Market Sale | -3,706 | 4.68 | -17,347.04 | -102,8% | |
| 2026-04-10 | Camblong Jurgi | Director, Officer, Chief Executive Officer | Open Market Sale | -3,732 | 4.72 | -17,607.58 | -104,4% | |
| 2026-04-10 | Camblong Jurgi | Director, Officer, Chief Executive Officer | Open Market Sale | -8,500 | 4.72 | -40,103.00 | -237,7% | |
| 2026-04-10 | Menu Philippe | Officer, Chief Medical Officer | Open Market Sale | -3,725 | 4.68 | -17,441.20 | -103,4% | |
| 2026-04-09 | Menu Philippe | Officer, Chief Medical Officer | Open Market Sale | -1,931 | 4.74 | -9,151.59 | -54,2% | |
| 2026-04-09 | Muken Ross | Officer, President | Open Market Sale | -1,950 | 4.74 | -9,238.91 | -54,8% | |
| 2026-04-09 | Van Well Daan | Officer, Chief Legal Officer | Open Market Sale | -1,988 | 4.74 | -9,424.31 | -55,9% | |
| 2026-04-09 | Camblong Jurgi | Director, Officer, Chief Executive Officer | Open Market Sale | -1,950 | 4.74 | -9,243.78 | -54,8% | |
| 2026-04-09 | Xu Zhenyu | Officer, Chief Scientific Officer | Open Market Sale | -1,936 | 4.74 | -9,176.45 | -54,4% | |
| 2026-04-08 | CARDOZA GEORGE | Officer, Chief Financial Officer | Open Market Sale | -1,403 | 4.85 | -6,800.62 | -40,3% | |
| 2026-04-08 | Van Well Daan | Officer, Chief Legal Officer | Open Market Sale | -2,861 | 4.85 | -13,862.12 | -82,2% | |
| 2026-04-08 | Muken Ross | Officer, President | Open Market Sale | -2,786 | 4.84 | -13,488.14 | -80,0% | |
| 2026-04-08 | Valente Manuela | Officer, Chief People Officer | Open Market Sale | -3,824 | 4.85 | -18,542.58 | -109,9% | |
| 2026-04-08 | Menu Philippe | Officer, Chief Medical Officer | Open Market Sale | -2,800 | 4.84 | -13,543.60 | -80,3% | |
| 2026-04-08 | Camblong Jurgi | Director, Officer, Chief Executive Officer | Open Market Sale | -2,800 | 4.84 | -13,553.12 | -80,3% | |
| 2026-04-08 | Xu Zhenyu | Officer, Chief Scientific Officer | Open Market Sale | -2,800 | 4.84 | -13,549.20 | -80,3% | |
| 2026-03-31 | Puylaert Kevin | Officer, Chief Sales Officer | Open Market Sale | -3 | 4.71 | -14.13 | -0,1% | |
| 2026-03-19 | Van Well Daan | Officer, Chief Legal Officer | Open Market Sale | -684 | 4.79 | -3,273.97 | -19,4% | |
| 2026-03-19 | CARDOZA GEORGE | Officer, Chief Financial Officer | Open Market Sale | -774 | 4.79 | -3,704.52 | -22,0% | |
| 2026-03-19 | Xu Zhenyu | Officer, Chief Scientific Officer | Open Market Sale | -608 | 4.78 | -2,907.03 | -17,2% | |
| 2026-03-19 | Puylaert Kevin | Officer, Chief Sales Officer | Open Market Sale | -33 | 4.76 | -157.08 | -0,9% | |
| 2026-03-19 | Menu Philippe | Officer, Chief Medical Officer | Open Market Sale | -608 | 4.79 | -2,912.81 | -17,3% | |
| 2026-03-19 | Muken Ross | Officer, President | Open Market Sale | -1,183 | 4.79 | -5,670.95 | -33,6% | |
| 2026-03-19 | Valente Manuela | Officer, Chief People Officer | Open Market Sale | -380 | 4.79 | -1,818.34 | -10,8% | |
| 2026-03-19 | Camblong Jurgi | Director, Officer, Chief Executive Officer | Open Market Sale | -4,486 | 4.77 | -21,410.33 | -126,9% |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| AKRE CAPITAL MANAGEMENT LLC | 3,719,140 | 17,368,384 | 41.12 |
| BANQUE PICTET & CIE SA | 2,208,280 | 10,312,668 | 24.41 |
| PRINCIPAL FINANCIAL GROUP INC | 1,399,442 | 6,535,394 | 15.47 |
| ROYCE & ASSOCIATES LP | 430,257 | 2,009,300 | 4.76 |
| Bank Pictet & Cie (Europe) AG | 255,200 | 1,191,784 | 2.82 |
| 1492 Capital Management LLC | 208,345 | 972,971 | 2.30 |
| Ensign Peak Advisors, Inc | 182,414 | 851,873 | 2.02 |
| MILLENNIUM MANAGEMENT LLC | 125,458 | 585,889 | 1.39 |
| GEODE CAPITAL MANAGEMENT, LLC | 92,596 | 432,423 | 1.02 |
| RENAISSANCE TECHNOLOGIES LLC | 83,000 | 387,610 | 0.92 |
| UBS Group AG | 61,901 | 289,078 | 0.68 |
| MORGAN STANLEY | 48,047 | 224,380 | 0.53 |
| Silverberg Bernstein Capital Management LLC | 47,815 | 223,296 | 0.53 |
| GROUP ONE TRADING LLC | 40,400 | 188,668 | 0.45 |
| Pathstone Holdings, LLC | 32,203 | 150,388 | 0.36 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 30,511 | 142,486 | 0.34 |
| GOLDMAN SACHS GROUP INC | 28,660 | 133,842 | 0.32 |
| XTX Topco Ltd | 11,760 | 54,919 | 0.13 |
| Quadrature Capital Ltd | 11,649 | 54,401 | 0.13 |
| PERKINS CAPITAL MANAGEMENT INC | 10,500 | 49,035 | 0.12 |